Guest Appearances
Executive Chairman of Opyl, Saurabh Jain, joined the Geeks Of The Valley podcast, a series that connects with global industry leaders to discuss emerging trends in venture capital, private equity, and innovation.
This episode, ‘Revolutionizing Global Healthcare Through AI,’ dives into how AI is reshaping clinical trials and why automation is needed to improve trial success rates.
Listen here: https://open.spotify.com/episode/1iS9p6CTJlpDTTfxnR5BGM
Opyl CTO, Damon Rasheed, join the brilliant Dr. Shikha Jain, MD, FACP, on the Oncology Overdrive podcast by Healio.
Dr. Jain is a board-certified hematology and oncology physician and a tenured Associate Professor of Medicine in the Division of Hematology and Oncology at the University of Illinois Cancer Center in Chicago. She also serves as the Director of Communication Strategies in Medicine and the Associate Director of Oncology Communication & Digital Innovation. Beyond her clinical and academic...
Executive Chairman, Saurabh Jain, joins hosts Joe and Jordan to discuss how TrialKey’s AI models to predicts clinical trial outcomes, as well as the clinical trial process.
Executive Chairman, Saurabh Jain, joined host Joana Inch, to discuss TrialKey’s proprietary large language AI-model, built on data from 350,000 trials, is now able to predict trial success with an impressive 92% accuracy. From analysing thousands of variables to spending years perfecting the model, TrialKey is reshaping the future of clinical research.
Executive Chairman, Saurabh Jain, joined host Niomi Hurly, to share insights into how AI is revolutionising clinical trial prediction and optimisation. In addition to learning more about how AI is able to bring benefits to this space, Saurabh also reflected on how to lead effectively in such a changing world.
Executive Chairman, Saurabh Jain, recently joined host, Kat Frey, to discuss the intersection of AI, ethics, meditation, and leadership. They delve into the future of technology and its impact on society.
Executive Chair Saurabh Jain together with CTO & Founder, Damon Rasheed, sat down with Nathan Moore. In this episode, they dive into the predictive analysis systems revolutionising clinical trial design and outcomes. With the costs of these trials often soaring, and their success rates lagging, the integration of artificial intelligence (AI) and big data stands to not only streamline the process but potentially save billions in healthcare spending.
Executive Chairman, Saurabh Jain, spoke with AI expert, Jordan Wilson about harnessing AI technologies for next-generation clinical trials.
Everyday AI is a daily livestream and podcast that helps everyday people grow their knowledge in AI. As of October 2023, Everyday AI is a Top 10 Tech Podcast on Spotify (out of 89K tech podcasts!)
Ep 287: Harnessing AI Technologies for Next-Generation Clinical Trials
Executive Chairman, Saurabh Jain and CTO Damon Rasheed joins Craig S. Smith the host, for an insightful conversation on how AI will benefit the advancement of medical breakthroughs through efficiency and greater accuracy in clinical trials using TrialKey.Tune in as they delve into the realm of healthcare, discussing AI’s impact in the industry and the trailblazers shaping its future such as TrialKey.
Hosted by Linda Vo, Executive Director Damon Rasheed has an insightful discussion on leadership, entrepreneurship, and the future of healthcare with AI.
Hosted by Sheila Kloefkorn, Saurabh Jain, Executive Chairman discusses his strategies for growth, personal transformation, and the synergies between different businesses. Perfect for entrepreneurs and business leaders!
Executive Chairman, Saurabh Jain, was a guest on the podcast hosted by James Short. Saurabh highlights his property portfolio, including a new Airbnb in Vaucluse, and delves into Opyl and TrialKey. He explains how TrialKey, likened to a ‘Renaissance Man,’ uses AI to learn from over 350,000 clinical trials to predict outcomes and provide trial design recommendations.
Hosted by Alex Elish, Saurabh shares his journey from being a software engineer to leading multiple tech startups and eventually becoming a CEO of a publicly listed company. His diverse experience in both technical and commercial roles has uniquely positioned him to lead Opyl and TrialKey, two companies at the forefront of AI-driven innovations in the clinical trial and biotech industries.
Discover how AI is revolutionising the clinical trial industry with Saurabh Jain on the AI Advantage Show, hosted by Richard Wray! Understand the critical role of AI in optimising trial design, patient recruitment, and phase predictions, setting new ethical standards in clinical research.
Hosted by Linda Vo, Saurabh Jain, Executive Chairman of Opyl and TrialKey, shared his insights on the profound impact of AI on healthcare, particularly in clinical trials.
Hosted by Thomas Watkins, Saurabh Jain, Executive Chairman discussed how our custom LLM turns vast amounts of unstructured data into structured, actionable insights, providing precise probabilities for trial success.
Executive Chairman, Saurabh Jain, spoke with Jess Larsen, co-founder of a biotech venture capital firm focused on preventive medicines and longevity, and founder of Graystoke Investments, and Graystoke Networks, brings his unique perspective to the table.
Executive Chairman, Saurabh Jain discussed how TrialKey, through its AI-driven trial design simulator, TrialGen, is enhancing clinical trials. They also discuss our recent work with one of our clients in designing their trial, showcasing the practical impact of our technology.
Watch it here.
Host, Mihir Jha spoke with Executive Chairman, Saurabh Jain, to discuss the daunting reality of clinical trials: most fail, and only a tiny fraction ever secure FDA approval.
An interview of Saurabh Jain, Executive Chairman of TrialKey, and Niv Dagan, Executive Director of PEAK Asset Management, on Peak TV. This video explores the groundbreaking world of AI-powered clinical trial optimization through Opyl’s innovative platform, TrialKey. They cover the Genesis of TrialKey, the TrialGen Design Simulator, and Why Invest in Opyl.
Saurabh Jain, Executive Chairman of Opyl, was a guest on The Curious Coconut Podcast in the episode titled “How AI can revolutionise clinical trials”. Hosted by Hai Thong Nguyen (ธง) and Aadityaa Gupta, the episode explores the future of AI in clinical trials.
Executive Chairman, Saurabh Jain’s recent interview with ausbiz where he discusses our new strategic partnership with Alithia Life Sciences Our new partnership that allows Alithia to leverage TrialKey’s advanced AI-driven simulation and predictive analytics in their clinical trial projects for data-driven biostatistical validation.
Watch the interview here.
Executive director Damon Rasheed joins Proactive’s Tylah Tully to discuss the non-exclusive strategic partnership the company has entered with Alithia Life Sciences, a contract research organisation (CRO) specialising in clinical research solutions.
Certainty in clinical trials starts here.
TrialKey stands as the market leader for clinical trial prediction and design optimization, with an accuracy rate of +92%
